News

1. Creative Biolabs Announces Therapeutic Antibody Engineering Services for Preclinical Development

   Creative Biolabs today announced the availability of its therapeutic antibody engineering services.

2. Creative Biolabs Expands AI-Assisted CAR/TCR Development Services

   Creative Biolabs expands its CAR/TCR development capabilities with AI-driven solutions designed to support receptor candidate screening, prioritize engineered T-cell designs, and identify potential safety and specificity risks earlier in development.

3. Creative Biolabs Expands Antibody Portfolio for HIV and HTLV Research

   Creative Biolabs has expanded its specialized antibody portfolio targeting structural and envelope proteins from HIV-1, HIV-2, and HTLV-1.

4. Creative Biolabs Expands R&D Services for Edible Plant-Derived Extracellular Vesicles

   Creative Biolabs officially announced today the expansion of its plant-derived extracellular vesicle development platform to support advancing research in natural nanoscale delivery systems.

5. Creative Biolabs Highlights Integrated Bispecific ADC Development Services for Biparatopic Programs

   Creative Biolabs, a global CRO specializing in antibody-drug conjugates (ADCs), is highlighting its integrated bispecific and biparatopic ADC development capabilities.

6. MyLabScope Reaches 55 Laboratories in Nigeria Pilot as It Builds a Pay-as-You-Go Diagnostic Network for Africa

   The platform is lowering the cost of laboratory digitalization while expanding patient booking, preventive health services, QR-verified results and diaspora-supported care.

7. Creative Biolabs Integrates Immunology and Microfluidic Solutions to Support Biotherapeutics Research

   Creative Biolabs boosts biotherapeutics research by combining specialized immunology assays with advanced microfluidics to help researchers profile immune responses and build flexible, fit‑for‑purpose workflows.

8. Creative Biolabs Targets Key Barriers in Lipid-Based Delivery

   Creative Biolabs expands functionalized lipid-based delivery system development capabilities, helping researchers address persistent challenges in targeting, carrier stability, biological responsiveness, and controlled payload release.

9. Health Canada Clears Updated Clinical Trial Protocol for Redsenol-1 Plus

   Clinical Trial Update on Redsenol-1 Plus for Cancer-Related Fatigue Research

10. Creative Biolabs Expands Advanced Single-Cell Multi-Omics and RNA Sequencing Solutions to Support Biomedical Discovery

    Creative Biolabs has expanded its single-cell analysis capabilities to support increasingly complex biomedical research applications.